Short Description
Wegovy 2.4 mg contains semaglutide, a GLP-1 receptor agonist used for weight management alongside a reduced-calorie diet and increased physical activity. It helps regulate appetite and food intake and may support weight loss and long-term weight maintenance in eligible patients.
What Is Wegovy 2.4mg?
Wegovy 2.4 mg contains semaglutide, a medicine that mimics the action of glucagon-like peptide-1 (GLP-1), a hormone involved in appetite regulation and blood glucose control.
It is used as part of a comprehensive weight-management programme for eligible adults with obesity or overweight accompanied by weight-related health conditions. Eligibility and approved uses may vary by country.
Uses
Wegovy 2.4 mg may be prescribed to:
Support weight loss in adults with obesity.
Support weight management in adults who are overweight and have at least one weight-related health condition.
Help maintain weight loss alongside dietary changes and increased physical activity.
The appropriate treatment and dose should be determined by a healthcare professional based on the patient's medical history, treatment response and applicable prescribing guidance.
How Does Wegovy Work?
Semaglutide activates GLP-1 receptors involved in appetite regulation. It helps increase feelings of fullness, reduce hunger and cravings, and decrease food intake. It also slows stomach emptying, which can influence appetite and digestion.
Weight changes generally develop over time rather than immediately. Results vary between individuals and depend on factors including treatment adherence, diet, physical activity and individual response.
How to Take Wegovy
Take Wegovy exactly as prescribed by your healthcare professional.
Frequency: The injection is generally administered once weekly on the same day each week.
Administration: Inject under the skin of the abdomen, thigh or upper arm, following the instructions supplied with the specific pen.
With or without food: The injection can generally be administered with or without meals.
Dose adjustments: Treatment is usually started at a lower dose and increased gradually to improve gastrointestinal tolerability. The 2.4 mg dose is a maintenance dose for appropriate patients, not the usual starting dose.
Missed dose: Instructions depend on how much time has passed since the missed injection. Follow the patient information leaflet or ask your pharmacist or prescriber for guidance.
Treatment changes: Do not increase, reduce or stop treatment without consulting your healthcare professional.
Do not share your injection pen with another person, even if the needle is changed. Follow the supplied instructions for needle disposal and pen use.
Important Safety Information
Before starting Wegovy, tell your doctor or pharmacist about your medical history and all medicines, vitamins, supplements and herbal products you use.
Use Wegovy with particular caution if you have:
A history of pancreatitis: Inflammation of the pancreas has been reported with semaglutide treatment.
Gallbladder problems: Including gallstones or previous gallbladder inflammation.
Kidney problems: Vomiting and diarrhoea can cause dehydration and may worsen kidney function.
Severe digestive problems: Including gastroparesis, a condition in which the stomach empties more slowly than normal.
Type 2 diabetes or diabetic retinopathy: Blood glucose levels and eye complications may require monitoring, particularly if you also use diabetes medicines.
A planned operation or procedure involving general anaesthesia or deep sedation: Tell the medical team that you use Wegovy because delayed stomach emptying may affect procedural planning.
A previous serious allergic reaction to semaglutide or any ingredient in the product.
Important medicine interactions include insulin and sulfonylureas, which can increase the risk of low blood sugar when used with semaglutide, as well as other GLP-1 receptor agonists. Wegovy may also affect the absorption of some oral medicines by slowing stomach emptying.
Check all potential interactions and precautions with your doctor or pharmacist before starting treatment or changing any medicines.
Pregnancy & Breastfeeding
Wegovy is not recommended during pregnancy because semaglutide may pose a risk to the developing baby. If you become pregnant or plan to conceive, contact your healthcare professional. Semaglutide should generally be discontinued at least two months before a planned pregnancy.
Wegovy is also not recommended during breastfeeding under the European product information because the potential risk to the infant cannot be excluded. Discuss suitable treatment options with your doctor or pharmacist if you are pregnant, planning a pregnancy or breastfeeding.
Side Effects
Like all medicines, Wegovy can cause side effects, although not everyone experiences them.
Common side effects include:
These effects are often more noticeable when treatment begins or the dose is increased.
Seek prompt medical attention if you experience severe, persistent abdominal pain, particularly if it spreads to your back; severe or persistent vomiting with signs of dehydration; sudden loss of vision; or symptoms of a serious allergic reaction, such as swelling of the face or throat or difficulty breathing.
This is not a complete list of side effects or warnings. Please refer to the product packaging and patient information leaflet supplied with your medicine for complete information and speak with your doctor or pharmacist if you have concerns.
Storage
Store Wegovy according to the instructions shown on the original product packaging.
Before first use, the pre-filled pen generally requires refrigeration at 2°C to 8°C.
Do not freeze the medicine or use it if it has been frozen.
Protect the product from light and keep it in its original carton where instructed.
After first use, follow the specific storage conditions and in-use expiry period stated in the patient information leaflet for your pen presentation.
Keep the medicine out of reach of children.
Do not use the medicine after its expiry date.
Storage conditions after first use may vary by product presentation and market. Check the supplied leaflet for the instructions applicable to your exact pen.